Sure.
That is a quick question that really needs a long in-depth answer, however, I will attempt brevity.
Biotron:
- Uses a piddling amount of money to achieve verifiable results with world class labs.
- Somehow has squeezed that tiny budget to produce about a dozen high quality human trials.
- Refuses to report positive findings without many caveats, so much so that the share price actually plummets on good news, despite achieving goals and producing positive results. I like that in a scientist.
- Went for the hard target, (E protein), instead of targeting the rapidly mutating Covid Spike Protein and if this all goes the way I am reading it, that could result in saving lives due to the effect on the cytokine storm. It is not just a quick stop-gap cashing in on a temporary solution.
That is just the top of the list. Quoting from the papers produced and used in other papers is a massive job that does not appear to appreciated on here, so forgive me if I do not go further.
- Forums
- ASX - By Stock
- Biotron Share Price Competition Jan 1 2022
Sure. That is a quick question that really needs a long in-depth...
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.77M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $26.66K | 804.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 296338 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 76443 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 296338 | 0.033 |
5 | 457406 | 0.032 |
3 | 350500 | 0.031 |
9 | 670666 | 0.030 |
2 | 250000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 76443 | 2 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 490546 | 3 |
0.040 | 113240 | 2 |
Last trade - 15.00pm 18/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |